Béchade C, Dambrine G, David-Pfeuty T, Esnault E, Calothy G
Institut Curie-Biologie, Centre Universitaire, Orsay, France.
J Virol. 1988 Apr;62(4):1211-8. doi: 10.1128/JVI.62.4.1211-1218.1988.
Avian retrovirus MH2 contains two oncogenes, v-mil and v-myc. We have previously shown that a spontaneous mutant of MH2 (PA200-MH2), expressing only the v-mil oncogene, is able to induce proliferation of quiescent neuroretina cells. In this study, we investigated the transforming and tumorigenic properties of v-mil. PA200 induced fibrosarcomas in about 60% of the injected chickens, whereas inoculation of MH2 resulted mainly in the appearance of kidney carcinomas. Analysis of several parameters of transformation showed that PA200, in contrast to MH2, induced only limited in vitro transformation of fibroblasts and neuroretina cells. These results suggest that v-myc is the major transforming and tumorigenic gene in MH2-infected cells. This low in vitro transforming capacity differentiates v-mil not only from other avian oncogenes, but also from the homologous murine v-raf gene.
禽逆转录病毒MH2含有两个癌基因,即v-mil和v-myc。我们之前已经表明,MH2的一个自发突变体(PA200-MH2)仅表达v-mil癌基因,能够诱导静止的神经视网膜细胞增殖。在本研究中,我们调查了v-mil的转化和致瘤特性。PA200在约60%的注射鸡中诱导出纤维肉瘤,而接种MH2主要导致肾癌的出现。对几个转化参数的分析表明,与MH2相比,PA200仅诱导成纤维细胞和神经视网膜细胞有限的体外转化。这些结果表明,v-myc是MH2感染细胞中的主要转化和致瘤基因。这种低体外转化能力不仅使v-mil与其他禽癌基因不同,也与同源的鼠v-raf基因不同。